• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC PLUS; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC PLUS; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number E200-33M
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Pericardial Effusion (3271)
Date of Event 09/24/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device remains implanted in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
Clinical information: crd_1032 - sh device registry, patient site id: (b)(6).It was reported that on (b)(6) 2024, a 33mm epic plus mitral valve was successfully implanted in a patient.Prior to procedure it's noted that patient was taking acetylsalicylic acid.The patient was administered 40,000 ie of heparin for procedure.The patient had a minimum activated clotting time (act) level of 158 seconds and a maximum act level of 576 seconds.There was no difficulty implanting the device, such as multiple manipulations.The patient was administered 350 mg of protamine.On (b)(6) 2024, it was noted via echocardiogram that the patient developed an 8mm anterolateral pericardial effusion.No cardiac tamponade was present.It's noted that the patient was on 3000 ie of mono-embolex at the time the pericardial effusion was discovered.There was no intervention performed or planned.There is no allegation of malfunction against the abbott device or procedure.The patient was discharged at the time of report.
 
Additional Manufacturer Narrative
The device was not returned for analysis.An event for patient effects of pericardial effusion was reported.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all defined manufacturing specifications.Based on the information received, the cause of the reported pericardial effusion could not be determined.The reported serious injury/illness/impairment was a result of case-specific circumstances.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC PLUS
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL LTDA. REG#3001883144
1301rua profvieira demendonça
bairro engenho nogueira 31.31 0-26
BR   31.310-260
Manufacturer Contact
karen krouse
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key21625846
Report Number2135147-2025-01364
Device Sequence Number6706241
Product Code LWR
UDI-Device Identifier05415067033109
UDI-Public(01)05415067033109(17)270830
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
P040021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/09/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberE200-33M
Device Catalogue NumberE200-33M
Device Lot NumberBR00041120
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/20/2025
Supplement Date Received by Manufacturer04/29/2025
Initial Report FDA Received Date03/17/2025
Supplement Report FDA Received Date05/09/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/31/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age65 YR
Patient SexMale
Patient Weight63 KG
-
-